Press Releases

Dec 11, 2017
LONDON , Dec. 11, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today the closing of the
Dec 05, 2017
LONDON , Dec. 05, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today that it intends to sell,
Nov 22, 2017
- 29th Annual Piper Jaffray Healthcare Conference on November 29, 2017 - - Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference on November 30, 2017 - LONDON , Nov. 22, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" or "the Company"), a biopharmaceutical company focused on